Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Clinical trial NCT06126510 · RECRUITING
Trial details
- NCT number
- NCT06126510
- Sponsor
- CNBG-Virogin Biotech (Shanghai) Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-18
- Primary completion
- 2025-07-17
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.